PDE6H

PDE6H encodes the inhibitory γ′ subunit of cone photoreceptor cGMP phosphodiesterase 6 (PDE6), functioning as a critical regulator of cGMP hydrolysis in the cone phototransduction cascade. PDE6H is expressed in the outer segments and synaptic terminals of all cone photoreceptor subtypes, where it constitutively suppresses PDE6 catalytic activity; unlike the rod isoform PDE6G, the cone γ subunit is constitutively phosphorylated at threonine 20 independently of light (PMID:8786098, PMID:25739440, PMID:19878658). Loss-of-function mutations in PDE6H cause autosomal-recessive incomplete achromatopsia in humans, though in mice the rod PDE6G subunit compensates functionally in cones, revealing species-specific redundancy (PMID:22901948, PMID:25739440). Beyond the retina, PDE6H loss elevates intracellular cGMP, suppresses mTORC1 signaling, induces G1 cell cycle arrest, and impairs mitochondrial function in cancer cells, indicating a cGMP-dependent role in cell growth regulation (PMID:38350962).

1. 1996 High

   Identification of PDE6H as the gene encoding the cone-specific inhibitory γ subunit of PDE6 established the molecular identity of a key phototransduction regulator and revealed its retina- and cone-restricted expression.

   Evidence cDNA cloning, Northern blot, in situ hybridization, and FISH mapping to chromosome 12p13 in human retina

   PMID:8786098

   Open questions at the time

   • Protein-level confirmation of PDE6H interaction with cone PDE6 catalytic subunits not shown
   • No functional assay of inhibitory activity on cone PDE6 holoenzyme
2. 2002 Medium

   Detection of PDE6H protein and an alternatively spliced transcript in mouse lung challenged the view that PDE6H is strictly retina-specific, raising the possibility of non-visual functions.

   Evidence Isoform-specific immunostaining and RT-PCR in Pde6g−/− mouse lung tissue

   PMID:11944991

   Open questions at the time

   • Functional significance of the lung-specific spliced transcript with frameshift unknown
   • No demonstration that PDE6H in lung regulates cGMP hydrolysis
   • Non-retinal expression not independently confirmed in other species
3. 2005 Medium

   A 5′ UTR variant in PDE6H that increased translational efficiency in vitro provided the first genetic link between PDE6H dysregulation and cone degeneration, suggesting that excess inhibitory γ subunit can pathologically elevate cGMP.

   Evidence In vitro transcription/translation assay of patient-derived variant, SSCP screening

   PMID:15629837

   Open questions at the time

   • No in vivo demonstration of PDE6H overexpression causing cone degeneration
   • Single variant in a small cohort; causality not established genetically
4. 2009 High

   Demonstrating that cone PDE6γ (PDE6H) is constitutively phosphorylated at T20 regardless of illumination—unlike the light-dependent phosphorylation of rod PDE6G at T22—revealed a fundamental kinetic distinction in how cone versus rod phototransduction is regulated.

   Evidence Transgenic mice with T22A/T35A substitutions; phosphorylation analysis in intact rods and cones under varying light conditions

   PMID:19878658

   Open questions at the time

   • Kinase responsible for constitutive T20 phosphorylation in cones not identified
   • Functional consequence of constitutive phosphorylation on cone PDE6 catalytic rate not measured
5. 2012 High

   Identification of a homozygous nonsense mutation (p.Ser12*) in PDE6H as the cause of autosomal-recessive incomplete achromatopsia in two independent families established PDE6H as a disease gene and confirmed its indispensable role in human cone phototransduction.

   Evidence Homozygosity mapping and Sanger sequencing in consanguineous families; immunohistochemistry localizing Pde6h to S and M/L cones in mouse retina

   PMID:22901948

   Open questions at the time

   • Mechanism by which loss of PDE6H leads to incomplete rather than complete achromatopsia not explained
   • No rescue experiment to confirm causality
6. 2015 High

   Pde6h knockout mice unexpectedly showed normal cone ERG responses because rod PDE6G substituted functionally in cones, revealing species-specific redundancy that explained why human PDE6H mutations cause disease but mouse knockouts do not.

   Evidence Pde6h−/− mice analyzed by ERG, immunohistochemistry for PDE6G in cone outer segments, and histomorphology

   PMID:25739440

   Open questions at the time

   • Whether PDE6G compensation occurs in any primate or large-animal model unknown
   • Molecular basis for species-specific ability of PDE6G to access cone PDE6 holoenzyme not determined
7. 2015 Medium

   Identification of Mef2d (acting synergistically with Crx) as a transcriptional activator of Pde6h placed PDE6H expression under the control of a photoreceptor gene-regulatory network, linking its cone-specific expression to defined transcription factors.

   Evidence Mef2d−/− mice showing reduced Pde6h transcript/protein; promoter co-activation assays

   PMID:25757744

   Open questions at the time

   • Direct binding of Mef2d to the Pde6h promoter not demonstrated by ChIP
   • Relative contributions of Mef2d versus Crx to Pde6h expression not quantified
8. 2016 Medium

   Phylogenetic analysis showing PDE6H arose via vertebrate whole-genome duplications, with zebrafish paralogs displaying distinct diurnal expression oscillations, suggested that PDE6H regulatory evolution adapts cone phototransduction to light-cycle demands.

   Evidence Comparative synteny, phylogenetics, in situ hybridization and expression profiling in zebrafish retina

   PMID:27296292

   Open questions at the time

   • Functional divergence among zebrafish PDE6H paralogs not tested by loss-of-function
   • Circadian regulation mechanism of PDE6H expression not identified
9. 2020 Medium

   Showing that thyroid hormone receptor TRαA directly activates the pde6h promoter during flounder metamorphosis established a hormonal axis controlling PDE6H transcription, linking systemic endocrine signaling to cone photoreceptor differentiation.

   Evidence Dual-luciferase reporter assay on pde6h promoter; T4 upregulation and thiourea suppression with pharmacological rescue in flounder

   PMID:32300306

   Open questions at the time

   • Whether thyroid hormone regulation of PDE6H is conserved in mammals not tested
   • Single fish species model; generalizability across teleosts uncertain
10. 2024 High

    PDE6H knockout in cancer cells elevated intracellular cGMP, suppressed mTORC1, impaired mitochondrial function, and induced G1 arrest and cell death—demonstrating a non-visual, cGMP-dependent growth-regulatory function of PDE6H that operates independently of the canonical PKG pathway.

    Evidence CRISPR knockout and siRNA knockdown in HCT116 cells; cGMP measurement, metabolomics, mTOR/cell cycle assays, mitochondrial function assays, xenograft tumor model

    PMID:38350962

    Open questions at the time

    • Direct molecular target linking elevated cGMP to mTORC1 suppression not identified
    • Relevance to endogenous PDE6H expression in non-transformed non-retinal tissues unclear
    • Whether effects are PDE6H-specific or shared with PDE6G not tested

• The structural basis of PDE6H interaction with cone PDE6 catalytic subunits, the kinase mediating constitutive T20 phosphorylation, and the mechanistic link between cGMP elevation and mTORC1 suppression remain unresolved.
• No crystal or cryo-EM structure of cone PDE6 holoenzyme with PDE6H
• Kinase for constitutive T20 phosphorylation not identified
• Mechanism connecting cGMP to mTORC1 independently of PKG unknown